![JNK and phosphorylated Bcl-2 predict multiple sclerosis clinical activity and glatiramer acetate therapeutic response - ScienceDirect JNK and phosphorylated Bcl-2 predict multiple sclerosis clinical activity and glatiramer acetate therapeutic response - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1521661619304619-ga1.jpg)
JNK and phosphorylated Bcl-2 predict multiple sclerosis clinical activity and glatiramer acetate therapeutic response - ScienceDirect
![Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis - Alexander Y Lau, WK Ip, Cheryl Au, KK Lau, Winnie Wong, KK Yip, Jonas Yeung, Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis - Alexander Y Lau, WK Ip, Cheryl Au, KK Lau, Winnie Wong, KK Yip, Jonas Yeung,](https://journals.sagepub.com/cms/10.1177/2055217317733485/asset/images/large/10.1177_2055217317733485-fig2.jpeg)
Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis - Alexander Y Lau, WK Ip, Cheryl Au, KK Lau, Winnie Wong, KK Yip, Jonas Yeung,
Influence of Chlorinating Agents on the Formation of Stable Biomarkers in Hair for the Retrospective Verification of Exposure | Analytical Chemistry
![Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl, Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl,](https://journals.sagepub.com/cms/10.1177/1352458513503597/asset/images/large/10.1177_1352458513503597-fig4.jpeg)
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl,
![Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease | Journal of Proteome Research Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease | Journal of Proteome Research](https://pubs.acs.org/cms/10.1021/acs.jproteome.0c00326/asset/images/large/pr0c00326_0004.jpeg)
Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease | Journal of Proteome Research
![Pharmacokinetics and pharmacodynamics of peginterferon beta‐1a in patients with relapsing‐remitting multiple sclerosis in the randomized ADVANCE study - Hu - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library Pharmacokinetics and pharmacodynamics of peginterferon beta‐1a in patients with relapsing‐remitting multiple sclerosis in the randomized ADVANCE study - Hu - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/d865b2b8-fbbc-45bd-9f7c-e4b9d11bf8fb/bcp12521-fig-0003-m.jpg)
Pharmacokinetics and pharmacodynamics of peginterferon beta‐1a in patients with relapsing‐remitting multiple sclerosis in the randomized ADVANCE study - Hu - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library
![Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl, Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl,](https://journals.sagepub.com/cms/10.1177/1352458513503597/asset/images/large/10.1177_1352458513503597-fig1.jpeg)
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl,
![CIMB | Free Full-Text | Alternate Causes for Pathogenesis of Exfoliation Glaucoma, a Multifactorial Elastotic Disorder: A Literature Review CIMB | Free Full-Text | Alternate Causes for Pathogenesis of Exfoliation Glaucoma, a Multifactorial Elastotic Disorder: A Literature Review](https://www.mdpi.com/cimb/cimb-44-00078/article_deploy/html/images/cimb-44-00078-g001.png)
CIMB | Free Full-Text | Alternate Causes for Pathogenesis of Exfoliation Glaucoma, a Multifactorial Elastotic Disorder: A Literature Review
![Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl, Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl,](https://journals.sagepub.com/cms/10.1177/1352458513503597/asset/images/large/10.1177_1352458513503597-fig5.jpeg)